Shigeta S

No ORCID on file · 5 papers in corpus · active 2021-2025
2025
International journal of molecular sciences ·doi:10.3390/ijms26125435

Epithelial ovarian cancer (EOC) is diagnosed at an advanced stage in over half of the patients and its prognosis remains unfavorable. CA125, one of the most frequent positive tumor markers in patients with EOC, has certain limitations. Ther…

2024
Radiology case reports ·doi:10.1016/j.radcr.2024.08.009

Arterioportal fistula (APF) combined with a visceral artery pseudoaneurysm is an exceptionally rare and critical vascular disorder of the abdominal viscera, with pseudoaneurysm rupture being potentially fatal and severe APF leading to porta…

2023
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol30090597

BackgroundEndometrial cancer is one of the most common gynecological malignancies. Because the findings mentioned in radiogram interpretation reports issued by diagnostic radiologists influence treatment strategies, we aimed to evaluate the…

2021
Gynecologic oncology reports ·doi:10.1016/j.gore.2021.100847

ObjectiveOvarian cancer (OC) is an intractable gynecological tumor, and frequent recurrence is experienced within a few years even after the complete eradication of tumor tissues by radical resection and neo-adjuvant chemotherapies. The con…

2021
Molecular cancer therapeutics ·doi:10.1158/1535-7163.mct-20-0809

Ovarian clear cell carcinoma (OCCC) is a rare, chemo-resistant subtype of ovarian cancer. To identify novel therapeutic targets and combination therapies for OCCC, we subjected a set of patient-derived ovarian cancer cell lines to arrayed h…